1. Recommended statement for over-the-counter aspirin-containing drug products labeled with cardiovascular related imagery Publication: Silver Spring, MD : Center for Drug Evaluation and Research, November 2017 Subject(s): AspirinDrug LabelingDrug PackagingNonprescription DrugsCardiovascular SystemHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Mixing, diluting, or repackaging biological products outside the scope of an approved biologics license application Publication: Silver Spring, MD : Center for Drug Evaluation and Research, January 2018 Subject(s): Biological ProductsDrug ApprovalDrug PackagingPrescription DrugsHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
3. Wholesale distributor verification requirement for saleable returned drug product: compliance policy Publication: Silver Spring, MD : Center for Drug Evaluation and Research, September 2019 Subject(s): Commerce -- legislation & jurisprudenceLegislation, DrugPharmaceutical Preparations -- standardsDrug LabelingDrug PackagingGuideline AdherenceHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.United States.
